Novel retinoblastoma treatment avoids chemotherapy: the effect of optimally timed combination therapy with angiogenic and glycolytic inhibitors on LH(BETA)T(AG) retinoblastoma tumors

PURPOSE: The purpose of this study was to evaluate the effect of optimally timed combination treatment with angiogenic and glycolytic inhibitors on tumor burden, hypoxia, and angiogenesis in advanced retinoblastoma tumors. METHODS: LH(BETA)T(AG) mice (n =30) were evaluated. Mice were divided into 5...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Houston, Samuel K, Piña, Yolanda, Murray, Timothy G, Boutrid, Hinda, Cebulla, Colleen, Schefler, Amy C, Shi, Wei, Celdran, Magda, Feuer, William, Merchan, Jaime, Lampidis, Ted J
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2011
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3037041/
https://ncbi.nlm.nih.gov/pubmed/21339806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S15179
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars